Etidronate

CAS No. 2809-21-4

Etidronate( —— )

Catalog No. M13855 CAS No. 2809-21-4

Etidronate (Didronel) is a human protein tyrosine phosphatase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 27 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Etidronate
  • Note
    Research use only, not for human use.
  • Brief Description
    Etidronate (Didronel) is a human protein tyrosine phosphatase inhibitor.
  • Description
    Etidronate (Didronel) is a human protein tyrosine phosphatase inhibitor.(In Vitro):Etidronic acid (Etidronate) (10 mM, 24 h) shows cytotoxicity, causes a decrease in the S-phase population and an increase in the G2/M population, induces p53 mutation in MCF-7 cells.Etidronic acid (100 nM, 24 h) induces osteoclast apoptosis, which displays characteristics of apoptosis, including chromatin condensation and changed cellular and nuclear morphology, detected by fluorescence microscopy.
  • In Vitro
    Etidronic acid (Etidronate) (10 mM, 24 h) shows cytotoxicity, causes a decrease in the S-phase population and an increase in the G2/M population, induces p53 mutation in MCF-7 cells.Etidronic acid (100 nM, 24 h) induces osteoclast apoptosis, which displays characteristics of apoptosis, including chromatin condensation and changed cellular and nuclear morphology, detected by fluorescence microscopy.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HBV
  • Recptor
    HAP| PTPase S| V-type proton ATPase catalytic subunit
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    2809-21-4
  • Formula Weight
    206.03
  • Molecular Formula
    C2H8O7P2
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 41 mg/mL (199.0 mM)
  • SMILES
    CC(O)(P(=O)(O)O)P(=O)(O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Grases F, et al. Circ J. 2007 Jul;71(7):1152-6.
molnova catalog
related products
  • Burfiralimab

    Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) targeted against waveform proteins, exhibiting anti-HBV properties and potential applications in rheumatoid arthritis research.

  • Canocapavir

    Canocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region of the HBV core protein, and can be used for the treatment of hepatitis B virus.

  • Helioxanthin derivat...

    Helioxanthin derivative 5-4-2 (Helioxanthin 5-4-2) is an analogue of helioxanthin that shows anti-HBV activity in vitro and can be used to study HBV.